Dolby Laboratories (NYSE:DLB) major shareholder Dagmar Dolby sold 100,000 shares of the stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $50.84, for a total value of $5,084,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Wednesday, August 9th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $51.20, for a total value of $2,560,000.00.
  • On Monday, August 7th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $51.26, for a total value of $2,563,000.00.
  • On Tuesday, August 8th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $51.13, for a total value of $5,113,000.00.
  • On Friday, August 4th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $51.13, for a total value of $5,113,000.00.
  • On Wednesday, August 2nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $52.03, for a total value of $5,203,000.00.
  • On Monday, July 31st, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $52.22, for a total value of $5,222,000.00.

Dolby Laboratories (NYSE DLB) traded up 0.02% during midday trading on Friday, hitting $50.00. The stock had a trading volume of 516,426 shares. The firm has a market cap of $5.13 billion, a P/E ratio of 25.58 and a beta of 0.79. The stock has a 50-day moving average of $51.28 and a 200-day moving average of $50.73. Dolby Laboratories has a 52 week low of $44.99 and a 52 week high of $55.02.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings results on Tuesday, July 25th. The electronics maker reported $0.75 EPS for the quarter, beating analysts’ consensus estimates of $0.65 by $0.10. The company had revenue of $305.67 million for the quarter, compared to analyst estimates of $296.88 million. Dolby Laboratories had a return on equity of 10.25% and a net margin of 19.02%. The company’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.62 earnings per share. Analysts forecast that Dolby Laboratories will post $1.99 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Monday, August 7th will be issued a $0.14 dividend. The ex-dividend date of this dividend is Thursday, August 3rd. This represents a $0.56 dividend on an annualized basis and a dividend yield of 1.12%. Dolby Laboratories’s dividend payout ratio (DPR) is 28.57%.

COPYRIGHT VIOLATION WARNING: This news story was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.dailypolitical.com/2017/08/11/dagmar-dolby-sells-100000-shares-of-dolby-laboratories-dlb-stock.html.

A number of equities research analysts have recently weighed in on the company. BidaskClub downgraded Dolby Laboratories from a “hold” rating to a “sell” rating in a research note on Saturday, June 10th. Zacks Investment Research downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Monday, May 1st. Finally, B. Riley reaffirmed a “buy” rating and set a $61.50 price target on shares of Dolby Laboratories in a research note on Friday, July 28th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company’s stock. Dolby Laboratories currently has a consensus rating of “Hold” and a consensus target price of $54.38.

Several hedge funds have recently modified their holdings of the stock. OxFORD Asset Management LLP raised its stake in shares of Dolby Laboratories by 45.6% in the second quarter. OxFORD Asset Management LLP now owns 64,862 shares of the electronics maker’s stock worth $3,176,000 after buying an additional 20,323 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Dolby Laboratories by 0.5% in the second quarter. Dimensional Fund Advisors LP now owns 536,657 shares of the electronics maker’s stock worth $26,276,000 after buying an additional 2,648 shares during the period. Virtu KCG Holdings LLC purchased a new stake in shares of Dolby Laboratories during the second quarter worth approximately $366,000. Renaissance Technologies LLC raised its stake in shares of Dolby Laboratories by 14.1% in the second quarter. Renaissance Technologies LLC now owns 1,549,100 shares of the electronics maker’s stock worth $75,844,000 after buying an additional 191,600 shares during the period. Finally, Advisor Group Inc. raised its stake in shares of Dolby Laboratories by 39.9% in the second quarter. Advisor Group Inc. now owns 7,761 shares of the electronics maker’s stock worth $379,000 after buying an additional 2,213 shares during the period. Institutional investors own 50.46% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.